Latest News about SWAV
Recent news which mentions SWAV
The Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges
January 15, 2021
From Benzinga
Stocks That Hit 52-Week Highs On Thursday
January 14, 2021
From Benzinga
The Daily Biotech Pulse: Alexion Pauses COVID-19 Study, NantKwest Readout, Organogenesis Jumps On Guidance, Trial Updates
January 14, 2021
From Benzinga
The Daily Biotech Pulse: Sarepta Gene Therapy Study Readout, Novavax Vaccine Supply Deal, 2 IPOs
January 08, 2021
From Benzinga
Stocks That Hit 52-Week Highs On Thursday
January 07, 2021
From Benzinga
The Daily Biotech Pulse: CureVac COVID-19 Vaccine Deal, Argenx Out-Licenses Neuromuscular Disorder Drug, Xencor's Oncology Collaboration
January 07, 2021
From Benzinga
From Benzinga
Stocks That Hit 52-Week Highs On Tuesday
January 05, 2021
From Benzinga
From Benzinga
Stocks That Hit 52-Week Highs On Tuesday
December 22, 2020
From Benzinga
BofA Positive On Medtech Stock ShockWave In The Long Run
December 01, 2020
Tickers
SWAV
From Benzinga
The Daily Biotech Pulse: Alnylam's Oxluma Snags Early FDA Approval, DBV Chief Scientific Officer To Depart, Decision Day For Liquidia
November 24, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Monday
November 23, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Friday
November 20, 2020
From Benzinga
The Daily Biotech Pulse: Aquestive's Positive FDA Meeting, Prevail Awarded Patent, Neuro-Oncology Conference Gets Underway
November 19, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Wednesday
November 18, 2020
From Benzinga
The Daily Biotech Pulse: Kazia Jumps On Data Readout, Clinical Hold On Cellectis' Blood Cancer Study Lifted
November 18, 2020
From Benzinga
The Daily Biotech Pulse: Setback For Alkermes, Boston Scientific's Recall, ALX-Zymeworks Oncology Collaboration
November 17, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Monday
November 16, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Friday
November 13, 2020
From Benzinga
The Daily Biotech Pulse: Urovant In M&A Deal, Sanofi's Binary Event, Conference Presentations
November 13, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Thursday
November 12, 2020
From Benzinga
The Daily Biotech Pulse: AstraZeneca's Cancer Drug Flunks COVID-19 Studies, Five Prime On a Roll, Morphosys, Xencor, Incyte Strike Cancer Deal
November 12, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Wednesday
November 11, 2020
From Benzinga
The Daily Biotech Pulse: Five Prime Skyrockets, Multiple Conference Presentations On Tap
November 11, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Tuesday
November 10, 2020
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.